v3.25.2
Fair Value of Financial Instruments
6 Months Ended
Jun. 30, 2025
Fair Value of Financial Instruments  
Fair Value of Financial Instruments

10.     Fair Value of Financial Instruments

The Company carries certain financial assets and financial liabilities at fair value in accordance with GAAP which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP permits entities to choose to measure many financial instruments and certain other items at fair value. The Company did not purchase or sell any financial assets or liabilities carried under the fair value option during the three and six months ended June 30, 2025 and 2024.

The following table presents the financial assets and financial liabilities reported at fair value under the fair value option, and the changes in fair value included in the Consolidated Statement of Operations – Net (loss) gain from fair value adjustments, at or for the periods ended as indicated:

Changes in Fair Values For Items Measured at Fair Value

Fair Value

Fair Value

Pursuant to Election of the Fair Value Option

 

Measurements at

 

Measurements at

For the three months ended June 30,

For the six months ended June 30,

Description

    

June 30, 2025

    

December 31, 2024

    

2025

    

2024

    

2025

    

2024

(In thousands)

 

  

 

  

  

 

  

 

  

 

  

Mortgage-backed securities

$

226

$

237

$

$

1

$

$

1

Other securities

 

13,718

 

13,355

 

(8)

 

(51)

 

180

 

(151)

Borrowed funds

 

47,552

 

48,795

 

1,664

 

107

 

1,324

 

(627)

Net gain (loss) from fair value adjustments

$

1,656

$

57

$

1,504

$

(777)

Included in the fair value of the financial assets and financial liabilities selected for the fair value option is the accrued interest receivable or payable for the related instrument. The Company reports as interest income or interest expense in the Consolidated Statement of Operations, the interest receivable or payable on the financial instruments selected for the fair value option at their respective contractual rates.

The borrowed funds had a contractual principal amount of $61.9 million at both June 30, 2025 and December 31, 2024. The fair value of borrowed funds includes accrued interest payable of $0.4 million at both June 30, 2025 and December 31, 2024.

The Company generally holds its interest-earning assets to maturity and settles its liabilities at maturity. However, fair value estimates are made at a specific point in time and are based on relevant market information. These estimates do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular instrument. Accordingly, as assumptions change, such as interest rates and prepayments, fair value estimates change, and these amounts may not necessarily be realized in an immediate sale.

Disclosure of fair value does not require fair value information for items that do not meet the definition of a financial instrument or certain other financial instruments specifically excluded from its requirements. These items include core deposit intangibles and other customer relationships, premises and equipment, leases, income taxes and equity.

Further, fair value disclosure does not attempt to value future income or business. These items may be material and accordingly, the fair value information presented does not purport to represent, nor should it be construed to represent, the underlying “market” or franchise value of the Company.

A description of the methods and significant assumptions utilized in estimating the fair value of the Company’s financial assets and liabilities that are carried at fair value on a recurring basis are as follows:

Level 1 – when quoted market prices are available in an active market. At June 30, 2025 and December 31, 2024, Level 1 included one mutual fund.

Level 2 – when quoted market prices are not available, fair value is estimated using quoted market prices for similar financial instruments and adjusted for differences between the quoted instrument and the instrument being valued. Fair value can also be estimated by using pricing models, or discounted cash flows. Pricing models primarily use market-based or independently sourced market parameters as inputs, including, but not limited to, yield curves, interest rates, equity or debt prices and credit spreads. In addition to observable market information, models also incorporate maturity and cash flow assumptions. At June 30, 2025 and December 31, 2024, Level 2 included mortgage-backed securities, CLOs, corporate debt, municipals, and interest rate swaps.

Level 3 – when there is limited activity or less transparency around inputs to the valuation, financial instruments are classified as Level 3. At June 30, 2025 and December 31, 2024, Level 3 included trust preferred securities owned, and junior subordinated debentures issued by the Company, as well as municipal bonds.

The methods described above may produce fair values that may not be indicative of net realizable value or reflective of future fair values. While the Company believes its valuation methods are appropriate and consistent with those of other market participants, the use of different methodologies, assumptions, and models to determine fair value of certain financial instruments could produce different estimates of fair value at the reporting date.

The following table sets forth the Company’s assets and liabilities that are carried at fair value on a recurring basis, including those reported at fair value under the fair value option, and the level that was used to determine their fair value, at June 30, 2025 and December 31, 2024:

Quoted Prices

in Active Markets

Significant Other

Significant Other

for Identical Assets

Observable Inputs

Unobservable Inputs

Total carried at fair value

(Level 1)

(Level 2)

(Level 3)

on a recurring basis

    

2025

    

2024

    

2025

    

2024

    

2025

    

2024

    

2025

    

2024

Assets:

 

(In thousands)

Securities available for sale:

Mortgage-backed securities

$

$

$

828,756

$

911,636

$

$

$

828,756

$

911,636

Other securities

 

12,291

 

11,890

 

532,434

 

554,914

 

18,306

 

19,465

 

563,031

 

586,269

Derivatives

 

 

 

43,929

 

54,700

 

 

 

43,929

 

54,700

Total assets

$

12,291

$

11,890

$

1,405,119

$

1,521,250

$

18,306

$

19,465

$

1,435,716

$

1,552,605

Liabilities:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Borrowings

$

$

$

$

$

47,552

$

48,795

$

47,552

$

48,795

Derivatives

 

 

 

32,080

 

20,396

 

 

 

32,080

 

20,396

Total liabilities

$

$

$

32,080

$

20,396

$

47,552

$

48,795

$

79,632

$

69,191

The following table sets forth the Company’s assets and liabilities that are carried at fair value on a recurring basis, classified within Level 3 of the valuation hierarchy for the periods indicated:  

For the three months ended

June 30, 2025

June 30, 2024

Trust preferred

Junior subordinated

Trust preferred

Junior subordinated

   

Municipals

   

securities

   

debentures

   

securities

   

debentures

(In thousands)

Beginning balance

$

18,000

$

1,474

$

49,103

$

1,460

$

48,622

Net gain (loss) from fair value adjustment of financial assets (1)

 

 

(46)

 

 

(2)

 

Net (gain) loss from fair value adjustment of financial liabilities (1)

 

 

 

(1,664)

 

 

(106)

Increase (decrease) in accrued interest

 

 

 

4

 

(1)

 

(24)

(Provision) benefit for credit losses

 

(439)

 

 

 

 

Change in unrealized gains (losses) included in other comprehensive loss-assets

 

(683)

 

 

 

 

Change in unrealized (gains) losses included in other comprehensive loss-liabilities

 

 

 

109

 

 

49

Ending balance

$

16,878

$

1,428

$

47,552

$

1,457

$

48,541

Changes in unrealized gains (losses) held at period end

$

(683)

$

$

2,177

$

$

2,330

(1) Presented in the Consolidated Statements of Operations under net (loss) gain from fair value adjustments.

For the six months ended

June 30, 2025

June 30, 2024

Trust preferred

Junior subordinated

Trust preferred

Junior subordinated

   

Municipals

   

securities

   

debentures

   

securities

   

debentures

(In thousands)

Beginning balance

$

18,000

$

1,465

$

48,795

$

1,437

$

47,850

Net gain (loss) from fair value adjustment of financial assets (1)

 

 

 

 

21

 

Net (gain) loss from fair value adjustment of financial liabilities (1)

 

 

(36)

 

(1,324)

 

 

629

Increase (decrease) in accrued interest

 

 

(1)

 

(24)

 

(1)

 

(32)

(Provision) benefit for credit losses

 

(439)

 

 

 

 

Change in unrealized gains (losses) included in other comprehensive loss-assets

 

(683)

 

 

 

 

Change in unrealized (gains) losses included in other comprehensive loss-liabilities

 

 

 

105

 

 

94

Ending balance

$

16,878

$

1,428

$

47,552

$

1,457

$

48,541

Changes in unrealized gains (losses) held at period end

$

(683)

$

$

2,177

$

$

2,330

(1) Presented in the Consolidated Statements of Operations under net (loss) gain from fair value adjustments.

The following tables present the quantitative information about recurring Level 3 fair value of financial instruments and the fair value measurements at the periods indicated:

June 30, 2025

Valuation

Input

Weighted

    

Fair Value

Technique

Unobservable

Range

Average

(Dollars in thousands)

Assets:

 

  

 

  

 

  

 

  

 

  

Municipals

$

16,878

 

Discounted cash flows

 

Spread over A rated Municipal Curves

 

5.9

%

n/a

Trust preferred securities

1,428

 

Discounted cash flows

 

Spread over 3-month SOFR

 

4.7

n/a

Liabilities:

 

  

 

  

 

  

 

  

  

Junior subordinated debentures

$

47,552

 

Discounted cash flows

 

Spread over 3-month SOFR

 

4.7

%

n/a

December 31, 2024

Valuation

Input

Weighted

    

Fair Value

Technique

Unobservable

Range

Average

(Dollars in thousands)

Assets:

 

  

 

  

 

  

 

  

 

  

Municipals

$

18,000

 

Sales approach

 

Reduction for planned expedited disposal

 

n/a

n/a

Trust preferred securities

1,465

 

Discounted cash flows

 

Spread over 3-month SOFR

 

4.3

%

n/a

Liabilities:

 

  

 

  

 

  

 

  

  

Junior subordinated debentures

$

48,795

 

Discounted cash flows

 

Spread over 3-month SOFR

 

4.3

%

n/a

The significant unobservable inputs used in the fair value measurement of the Company’s trust preferred securities and junior subordinated debentures valued under Level 3 at June 30, 2025 and December 31, 2024, are the effective yields used in the cash flow models. Significant increases or decreases in the effective yield in isolation would result in a significantly lower or higher fair value measurement.

The following table sets forth the Company’s assets and liabilities that are carried at fair value on a non-recurring basis and the level that was used to determine their fair value at June 30, 2025 and December 31, 2024:

Quoted Prices

    

    

    

    

    

in Active Markets

Significant Other

Significant Other

for Identical Assets

Observable Inputs

Unobservable Inputs

Total carried at fair value

(Level 1)

(Level 2)

(Level 3)

on a non-recurring basis

    

2025

    

2024

    

2025

    

2024

    

2025

    

2024

    

2025

    

2024

 

(In thousands)

Assets:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Impaired loans

$

$

$

$

$

26,318

$

16,784

$

26,318

$

16,784

Total assets

$

$

$

$

$

26,318

$

16,784

$

26,318

$

16,784

The following tables present the qualitative information about non-recurring Level 3 fair value of financial instruments and the fair value measurements at the periods indicated:

    

At June 30, 2025

 

    

Fair Value

    

Valuation Technique

    

Unobservable Input

    

Range

    

Weighted Average

 

(Dollars in thousands)

 

Assets:

 

  

 

  

 

  

 

  

 

  

Impaired loans

 

$

9,703

Income approach

Capitalization rate

5.5 to 6.5

%  

5.7

%

Impaired loans

 

$

15,283

Sales approach

Adjustment to sales comparison value

-25.0 to 10.0

%  

(6.4)

%

 

Reduction for planned expedited disposal

15.0

%

15.0

%

Impaired loans

 

$

1,332

Discounted Cashflow

Discount Rate

8.3

%  

8.3

%

 

Probability of Default

25.0

%  

25.0

%

    

At December 31, 2024

 

    

Fair Value

    

Valuation Technique

    

Unobservable Input

    

Range

    

Weighted Average

 

(Dollars in thousands)

 

Assets:

 

  

 

  

 

  

 

  

 

  

Impaired loans

 

$

4,121

Sales approach

Adjustment to sales comparison value

-

%  

-

%

Reduction for planned expedited disposal

15.0

%

15.0

%

 

Impaired loans

 

$

2,453

Discounted Cashflow

Discount Rate

9.3% to 10.0

%  

9.5

%

 

Probability of Default

25.0% to 50.0

%  

33.2

%

Impaired loans

 

$

10,210

Income approach

Capitalization rate

4.8% to 6.5

%

5.7

%

The weighted average for unobservable inputs for collateral-dependent loans is based on the relative fair value of the loans.

The Company did not have any liabilities that were carried at fair value on a non-recurring basis at June 30, 2025 and December 31, 2024.

The methods and assumptions used to estimate fair value at June 30, 2025 and December 31, 2024 are as follows:

Securities:

The fair values of securities are contained in Note 4 (“Securities”) of the Notes to Consolidated Financial Statements. Fair value is based upon quoted market prices, where available. If a quoted market price is not available, fair value is estimated using quoted market prices for similar securities and adjusted for differences between the quoted instrument and the instrument being valued. When there is limited activity or less transparency around inputs to the valuation, securities are valued using discounted cash flows.

Impaired Loans:

For impaired loans, fair value is generally estimated by discounting management’s estimate of future cash flows with a discount rate commensurate with the risk associated with such assets or, for collateral dependent loans, 85% of the

appraised or internally estimated value of the property. See Note 5 (“Loans”) of the Notes to the Consolidated Financial Statements.

Junior Subordinated Debentures:

The fair value of the junior subordinated debentures was developed using a credit spread based on stated spreads for recently issued subordinated debt instruments for issuers of similar asset size and credit quality of the Company and with similar durations adjusting for differences in the junior subordinated debt’s credit rating, liquidity, and time to maturity. The unrealized net gain/loss attributable to changes in our own credit risk was determined by adjusting the fair value as determined in the proceeding sentence by the average rate of default on debt instruments with a similar debt rating as our junior subordinated debentures, with the difference from the original calculation and this calculation resulting in the instrument-specific unrealized gain/loss.

Derivatives:

The fair value of interest rate swaps is based upon broker quotes.

The following tables set forth the carrying amounts and estimated fair values of selected financial instruments based on the assumptions described above used by the Company in estimating fair value at the periods indicated:

    

June 30, 2025

Carrying

Fair

    

Amount

    

Value

    

Level 1

    

Level 2

    

Level 3

 

(In thousands)

Assets:

 

  

 

  

 

  

 

  

 

  

Cash and due from banks

$

150,123

$

150,123

$

150,123

$

$

Securities held-to-maturity

 

  

 

  

 

  

 

  

 

  

Mortgage-backed securities

 

7,826

 

7,146

 

 

7,146

 

Other securities

 

43,005

 

37,940

 

 

 

37,940

Securities available for sale

 

  

 

  

 

  

 

  

 

  

Mortgage-backed securities

 

828,756

 

828,756

 

 

828,756

 

Other securities

 

563,031

 

563,031

 

12,291

 

532,434

 

18,306

Loans held for investment, net of fees and costs

 

6,709,601

 

6,424,090

 

 

 

6,424,090

FHLB-NY stock

 

23,773

 

23,773

 

 

23,773

 

Accrued interest receivable

 

59,607

 

59,607

 

 

59,607

 

Derivatives

 

43,929

 

43,929

 

 

43,929

 

Liabilities:

 

  

 

  

 

  

 

  

 

  

Deposits

$

7,289,352

$

7,285,829

$

4,836,728

$

2,449,101

$

Borrowed Funds

 

600,171

 

571,849

 

 

524,297

 

47,552

Accrued interest payable

 

12,900

 

12,900

 

 

12,900

 

Derivatives

 

32,080

 

32,080

 

 

32,080

 

    

December 31, 2024

Carrying

Fair

    

Amount

    

Value

    

Level 1

    

Level 2

    

Level 3

(In thousands)

Assets:

 

  

 

  

 

  

 

  

 

  

Cash and due from banks

$

152,574

$

152,574

$

152,574

$

$

Securities held-to-maturity

 

  

 

  

 

  

 

  

 

  

Mortgage-backed securities

 

7,836

 

6,903

 

 

6,903

 

Other securities

 

43,649

 

37,815

 

 

 

37,815

Securities available for sale

 

  

 

  

 

  

 

  

 

  

Mortgage-backed securities

 

911,636

 

911,636

 

 

911,636

 

Other securities

 

586,269

 

586,269

 

11,890

 

554,914

 

19,465

Loans held for sale

 

70,098

 

70,098

 

 

 

70,098

Loans held for investment, net of fees and costs

 

6,745,848

 

6,506,439

 

 

 

6,506,439

FHLB-NY stock

 

38,096

 

38,096

 

 

38,096

 

Accrued interest receivable

 

62,036

 

62,036

 

 

62,036

 

Derivatives

 

54,700

 

54,700

 

 

54,700

 

Liabilities:

 

  

 

  

 

  

 

  

 

  

Deposits

$

7,178,933

$

7,148,847

$

4,528,769

$

2,620,078

$

Borrowed Funds

 

916,054

 

887,312

 

 

838,517

 

48,795

Accrued interest payable

 

12,275

 

12,275

 

 

12,275

 

Derivatives

 

20,396

 

20,396

 

 

20,396